Gozellix®, after radiolabeling with 68 Ga, is indicated for PET scanning of PSMA positive lesions in men with prostate cancer who have suspected metastasis and are candidates for initial definitive ...
Setmelanotide is a melanocortin-4 receptor (MC4R) agonist designed to treat hyperphagia and obesity. Rhythm is evaluating setmelanotide in a global Phase 3 trial in patients with acquired hypothalamic ...
1h
DelveInsight's "ROCKLATAN/ROCLANDA Market Size, Forecast, and Market Insight Report" highlights the details around ...
The rollout of USDC follows Circle and SBI Holdings securing regulatory approval from the Japan Financial Services Agency ...
THURSDAY, March 20, 2025 (HealthDay News) -- The Trump administration is weighing elimination of the U.S. Centers for Disease ...
DelveInsight's "CABLIVI Market Size, Forecast, and Market Insight Report" highlights the details around CABLIVI, a von ...
Unions warn about effect on vital services after chancellor confirms job cuts Unions have warned that as many as 50,000 ...
Moreover, the expanding e-commerce sector and the proliferation of direct-to-consumer brands have made skincare supplements more accessible to a global audience. Technological advancements in ...
Can-Fite BioPharma Ltd announced that it initiated a pivotal phase 3 psoriasis study of its oral drug Piclidenoson with the U.S. Food and Drug Administration (FDA) and the European Medicines ...
1don MSN
The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback